One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The mirror CAPD row prints below 10 mL/min; the dated official label includes 10 or below. Treatment and prophylaxis schedules also differ.
What to reconcile: Preserve the discrepancy; use the exact population, modality and indication. Do not transfer CAPD guidance to automated PD or CRRT.
Open this note and its source referencesTreatment, prophylaxis and dialysis schedules differ. Confirm duration and modality.
Dialysis evidence: A regimen is reported in selected content
Adult oral regimens; treatment lasts 5 days unless the dialysis row specifies a single dose.
| CrCl / modality | Treatment | Prophylaxis |
|---|---|---|
| Above 30 through 60 mL/min | 30 mg twice daily | 30 mg daily |
| Above 10 through 30 mL/min | 30 mg daily | 30 mg every other day |
| HD, CrCl 10 or below | 30 mg immediately then after every session; duration no more than 5 days | 30 mg immediately then after alternate sessions |
| CAPD, CrCl 10 or below | Single 30 mg dose immediately | 30 mg immediately then weekly |
| ESRD without dialysis | Not recommended | Not recommended |
Prophylaxis continues for the source-defined exposure/outbreak duration, not automatically 5 days. CAPD evidence is not an automated-PD or CRRT schedule. The older official label's CAPD boundary includes exactly 10, unlike the selected mirror. Adult renal schedules do not establish pediatric renal doses.
RDM61-official-oseltamivir-bf8fc38196-C1 · Source locator: 2.4 and Table 2
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=oseltamivir&s1=RDM61-official-oseltamivir-bf8fc38196&h1=2b8f9d15c249bed0256554f6c69fcb54d427abaf3ed1a377bee230157f136012